SETD2 and acute myeloid leukemia: Introduction of three sgRNAs targeting the Setd2 SET domain in SpCas9-expressing MLL-AF9/NrasG12D AML cells led to a strong depletion of transduced cells over time, as shown before48 (Fig. 6a).